In 2000, Chuanglong Yao was appointed CEO of Charmacy Pharmaceutical Co., Ltd. (HKG:2289). First, this article will compare CEO compensation with compensation at similar sized companies. Next, we’ll consider growth that the business demonstrates. And finally – as a second measure of performance – we will look at the returns shareholders have received over the last few years. The aim of all this is to consider the appropriateness of CEO pay levels.

View our latest analysis for Charmacy Pharmaceutical

How Does Chuanglong Yao’s Compensation Compare With Similar Sized Companies?

At the time of writing, our data says that Charmacy Pharmaceutical Co., Ltd. has a market cap of HK$771m, and reported total annual CEO compensation of CN¥714k for the year to December 2019. That’s actually a decrease